{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T17:08:37Z","timestamp":1742922517676,"version":"3.40.3"},"publisher-location":"Cham","reference-count":19,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030179373"},{"type":"electronic","value":"9783030179380"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-17938-0_45","type":"book-chapter","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T08:49:05Z","timestamp":1556614145000},"page":"513-521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["On Identifying Candidates for Drug Repurposing for the Treatment of Ulcerative Colitis using Gene Expression Data"],"prefix":"10.1007","author":[{"given":"Suyeon","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishwor","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesham","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,13]]},"reference":[{"key":"45_CR1","doi-asserted-by":"publisher","first-page":"16022","DOI":"10.1038\/ncomms16022","volume":"8","author":"Bin Chen","year":"2017","unstructured":"Chen, B., et al.: Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets. Nat. Commun. 8, ncomms16022 (2017)","journal-title":"Nature Communications"},{"issue":"33","key":"45_CR2","doi-asserted-by":"publisher","first-page":"52928","DOI":"10.18632\/oncotarget.10608","volume":"7","author":"AA Chumanevich","year":"2016","unstructured":"Chumanevich, A.A., et al.: Repurposing the anti-malarial drug, quinacrine: new anti-colitis properties. Oncotarget 7(33), 52928 (2016)","journal-title":"Oncotarget"},{"issue":"2","key":"45_CR3","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1053\/j.gastro.2009.10.037","volume":"138","author":"EF De Zoeten","year":"2010","unstructured":"De Zoeten, E.F., Wang, L., Sai, H., Dillmann, W.H., Hancock, W.W.: Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice. Gastroenterology 138(2), 583\u2013594 (2010)","journal-title":"Gastroenterology"},{"doi-asserted-by":"crossref","unstructured":"Edwards, A.J., Pender, S.L.: Histone deacetylase inhibitors and their potential role in inflammatory bowel diseases (2011)","key":"45_CR4","DOI":"10.1042\/BST0391092"},{"issue":"8","key":"45_CR5","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.4049\/jimmunol.176.8.5015","volume":"176","author":"R Glauben","year":"2006","unstructured":"Glauben, R., et al.: Histone hyperacetylation is associated with amelioration of experimental colitis in mice. J. Immunol. 176(8), 5015\u20135022 (2006)","journal-title":"J. Immunol."},{"issue":"5","key":"45_CR6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1136\/gut.2007.134650","volume":"57","author":"R Glauben","year":"2008","unstructured":"Glauben, R., et al.: Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice. Gut 57(5), 613\u2013622 (2008)","journal-title":"Gut"},{"key":"45_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.csbj.2019.01.001","volume":"17","author":"L Grenier","year":"2019","unstructured":"Grenier, L., Hu, P.: Computational drug repurposing for inflammatory bowel disease using genetic information. Comput. Struct. Biotechnol. J. 17, 127\u2013135 (2019)","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"8","key":"45_CR8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00011-011-0325-6","volume":"60","author":"XL Huang","year":"2011","unstructured":"Huang, X.L., et al.: PI3K\/Akt signaling pathway is involved in the pathogenesis of ulcerative colitis. Inflamm. Res. 60(8), 727\u2013734 (2011)","journal-title":"Inflamm. Res."},{"issue":"Suppl. 1","key":"45_CR9","first-page":"D355","volume":"38","author":"M Kanehisa","year":"2009","unstructured":"Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M., Hirakawa, M.: KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 38(Suppl. 1), D355\u2013D360 (2009)","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"45_CR10","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1158\/1078-0432.CCR-12-2623","volume":"19","author":"MW Khan","year":"2013","unstructured":"Khan, M.W., et al.: PI3K\/Akt signaling is essential for communication between tissue-infiltrating mast cells, macrophages, and epithelial cells in colitis-induced cancer. Clin. Cancer Res. 19(9), 2342\u20132354 (2013)","journal-title":"Clin. Cancer Res."},{"issue":"D1","key":"45_CR11","doi-asserted-by":"publisher","first-page":"D558","DOI":"10.1093\/nar\/gkx1063","volume":"46","author":"A Koleti","year":"2017","unstructured":"Koleti, A., et al.: Data portal for the library of integrated network-based cellular signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response data. Nucleic Acids Res. 46(D1), D558\u2013D566 (2017)","journal-title":"Nucleic Acids Res."},{"issue":"5795","key":"45_CR12","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb, J., et al.: The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313(5795), 1929\u20131935 (2006)","journal-title":"Science"},{"key":"45_CR13","first-page":"320","volume":"6","author":"L Lin","year":"2016","unstructured":"Lin, L., Sun, Y., Wang, D., Zheng, S., Zhang, J., Zheng, C.: Celastrol ameliorates ulcerative colitis-related colorectal cancer in mice via suppressing inflammatory responses and epithelial-mesenchymal transition. Front. Pharmacol. 6, 320 (2016)","journal-title":"Front. Pharmacol."},{"issue":"9","key":"45_CR14","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1136\/gut.2008.157297","volume":"57","author":"D Massey","year":"2008","unstructured":"Massey, D., Bredin, F., Parkes, M.: Use of sirolimus (rapamycin) to treat refractory Crohn\u2019s disease. Gut 57(9), 1294\u20131296 (2008)","journal-title":"Gut"},{"issue":"12","key":"45_CR15","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1016\/j.crohns.2014.08.014","volume":"8","author":"M Mutalib","year":"2014","unstructured":"Mutalib, M., et al.: The use of sirolimus (rapamycin) in the management of refractory inflammatory bowel disease in children. J. Crohn\u2019s Colitis 8(12), 1730\u20131734 (2014)","journal-title":"J. Crohn\u2019s Colitis"},{"doi-asserted-by":"crossref","unstructured":"Sheridan, C., Downward, J.: Inhibiting the RAS-PI3K pathway in cancer therapy. In: The Enzymes, vol. 34, pp. 107\u2013136. Elsevier (2013)","key":"45_CR16","DOI":"10.1016\/B978-0-12-420146-0.00005-6"},{"issue":"96","key":"45_CR17","doi-asserted-by":"publisher","first-page":"96ra77","DOI":"10.1126\/scitranslmed.3001318","volume":"3","author":"M Sirota","year":"2011","unstructured":"Sirota, M., et al.: Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci. Transl. Med. 3(96), 96ra77 (2011)","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"45_CR18","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/nn.4618","volume":"20","author":"HC So","year":"2017","unstructured":"So, H.C., et al.: Analysis of genome-wide association data highlights candidates for drug repositioning in psychiatry. Nat. Neurosci. 20(10), 1342 (2017)","journal-title":"Nat. Neurosci."},{"issue":"4","key":"45_CR19","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/imm.12096","volume":"139","author":"H Yin","year":"2013","unstructured":"Yin, H., et al.: Sirolimus ameliorates inflammatory responses by switching the regulatory T\/T helper type 17 profile in murine colitis. Immunology 139(4), 494\u2013502 (2013)","journal-title":"Immunology"}],"container-title":["Lecture Notes in Computer Science","Bioinformatics and Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-17938-0_45","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T08:46:59Z","timestamp":1710233219000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-17938-0_45"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030179373","9783030179380"],"references-count":19,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-17938-0_45","relation":{},"ISSN":["0302-9743","1611-3349"],"issn-type":[{"type":"print","value":"0302-9743"},{"type":"electronic","value":"1611-3349"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"13 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"IWBBIO","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"International Work-Conference on Bioinformatics and Biomedical Engineering","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Granada","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Spain","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2019","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"8 May 2019","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"10 May 2019","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"7","order":9,"name":"conference_number","label":"Conference Number","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"iwbbio2019","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"http:\/\/iwbbio.ugr.es\/","order":11,"name":"conference_url","label":"Conference URL","group":{"name":"ConferenceInfo","label":"Conference Information"}}]}}